An Amyris demonstration facility in Brazil. Credit: Noah Friedman-Rudovsky. In its early years, biotech company Amyris described itself as a start-up “applying its proprietary breakthrough ...

Amyris missed sales and earnings estimates. The company faces supply chain challenges. In addition, investors are selling shares after learning that the company is raising capital through the issuance ...

Zymergen's CEO recently stepped down after telling investors the well-funded company he started with former Amyris employees in 2011 wouldn't have any material revenue to report this year or next.

Add Yahoo as a preferred source to see more of our stories on Google. Another day, another brand. Prices range from $14 to $19 for first-time purchases. (Many of the products are refillable, and ...

EMERYVILLE, Calif., Nov. 8, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS) ("Amyris"), a leading synthetic biotechnology company accelerating the world to sustainable consumption through its ...

The climb up the steel steps is dizzying–like ascending the tower of a European church, except the steps lead to a platform bolted to the side of a gleaming new chemical plant. Here in Brazil, under a ...

EMERYVILLE, Calif., Dec. 23, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS) ("Amyris"), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption ...

Synthetic-biology company Amyris (NASDAQ: AMRS) had an absolutely awful day on the stock exchange Wednesday, due to an earnings report that fell well short of expectations. Investors mercilessly ...

Forbes contributors publish independent expert analyses and insights. Making wealth creation easy, accessible and transparent. Jobless claims were the story of the day, with numbers continuing to ...

Forbes contributors publish independent expert analyses and insights. Making wealth creation easy, accessible and transparent. Is the pain over for stocks now? Bitcoin appears to have stabilized (for ...

Amyris Inc. went public Tuesday in an $85 million initial public stock offering, sending shares of the Emeryville company 3 percent higher on the first trading day. “The worst thing on the first day ...

EMERYVILLE, Calif., July 28, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its ...